surf break copy_edited.jpg
surbreak-19.png
Search

Functional Fluidics Cell Biomarkers May Prove to be Effective Surrogate Endpoints for Sickle Cell

Functional Fluidics officially announced the publication of its two-year study, demonstrating that its red blood cell (RBC) health biomarkers can identify individuals with sickle cell disease at greatest risk for more severe outcomes. Further research is needed to determine the clinical value of stratifying patients according to these RBC health biomarkers. Assessing RBC health could help healthcare providers identify patients at risk for severe disease outcomes so that they can intervene earlier. Functional Fluidics is a diagnostics company striving to be the gold standard for red blood cell health.


CONTINUE READING

Recent Posts

See All

Spring has sprung across the U.S., and many of you are probably ready to hit the course and outdoor courts. But a recent injury may be interrupting your golf game or tennis match. If you’re hesitant o

WM360_logo-18.png